Comprehensive analysis of PTEN status in breast carcinomas (Q42519337)

1 November 2017

Comprehensive analysis of PTEN status in breast carcinomas (English)

1 reference

1 November 2017

Christine Tunon de Lara

object named as

Christine Tunon de Lara

9

0 references

author name string

Natalie Jones

1

1 reference

1 November 2017

Françoise Bonnet

2

1 reference

1 November 2017

Sana Sfar

3

1 reference

1 November 2017

Marie Lafitte

4

1 reference

1 November 2017

Delfine Lafon

5

1 reference

1 November 2017

Ghislaine Sierankowski

6

1 reference

1 November 2017

Véronique Brouste

7

1 reference

1 November 2017

Guillaume Banneau

8

1 reference

1 November 2017

Marc Debled

10

1 reference

1 November 2017

Gaëtan MacGrogan

11

1 reference

1 November 2017

Michel Longy

12

1 reference

1 November 2017

Nicolas Sevenet

13

1 reference

1 November 2017

language of work or name

English

0 references

publication date

12 February 2013

1 reference

International Journal of Cancer

1 November 2017

1 reference

1 November 2017

133

1 reference

1 November 2017

2

1 reference

1 November 2017

323-334

1 reference

HER-2 testing in breast cancer using parallel tissue-based methods

1 November 2017

1 reference

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

Somatic mutation and gain of copy number of PIK3CA in human breast cancer

21 January 2018

1 reference

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

21 January 2018

1 reference

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

21 January 2018

1 reference

PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer

21 January 2018

1 reference

3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma

21 January 2018

1 reference

Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer

21 January 2018

1 reference

The Akt pathway in human breast cancer: a tissue-array-based analysis

21 January 2018

1 reference

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

21 January 2018

1 reference

Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables

21 January 2018

1 reference

Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas.

21 January 2018

1 reference

Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.

21 January 2018

1 reference

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

PTEN: a new guardian of the genome.

21 January 2018

1 reference

Tenets of PTEN tumor suppression

21 January 2018

1 reference

Subtle variations in Pten dose determine cancer susceptibility

21 January 2018

1 reference

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

Essential role for nuclear PTEN in maintaining chromosomal integrity

21 January 2018

1 reference

Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner

21 January 2018

1 reference

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

21 January 2018

1 reference

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

21 January 2018

1 reference

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

21 January 2018

1 reference

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

21 January 2018

1 reference

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

21 January 2018

1 reference

Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

21 January 2018

1 reference

Waved aCGH: to smooth or not to smooth.

21 January 2018

1 reference

Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features

21 January 2018

1 reference

Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers

21 January 2018

1 reference

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups

21 January 2018

1 reference

PIK3CA mutation associates with improved outcome in breast cancer.

21 January 2018

1 reference

PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer

21 January 2018

1 reference

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs

21 January 2018

1 reference

Novel patterns of genome rearrangement and their association with survival in breast cancer

21 January 2018

1 reference

Assessment of palindromes as platforms for DNA amplification in breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28021

1 reference

1 November 2017

1 reference